Endocrine and Bone Monitoring in Boys with Duchenne Muscular Dystrophy; Do we adhere to the standards of care?

Henderson, A; Harley, G; Horrocks, I; Joseph, S; Dunne, J; Pysden, K; Mushtaq, T; Wong, S C; Childs, A M

Henderson, A; Harley, G; Horrocks, I; Joseph, S; Dunne, J; Pysden, K; Mushtaq, T; Wong, S C; Childs, A M.

Affiliation

Henderson A; Department of Paediatric Neurology, Leeds Children's Hospital, UK.
Harley G; Department of Paediatric Endocrinology, Royal Hospital for Children Glasgow, UK.
Horrocks I; Department of Paediatric Neurology, Royal Hospital for Children Glasgow, UK.
Joseph S; Department of Paediatric Neurology, Royal Hospital for Children Glasgow, UK.
Dunne J; Department of Paediatric Neurology, Royal Hospital for Children Glasgow, UK.
Pysden K; Department of Paediatric Neurology, Leeds Children's Hospital, UK.
Mushtaq T; Department of Paediatric Endocrinology, Leeds Children's Hospital, UK.
Wong SC; Department of Paediatric Endocrinology, Royal Hospital for Children Glasgow, UK.
Childs AM; Department of Paediatric Neurology, Leeds Children's Hospital, UK.

J Neuromuscul Dis ; 10(6): 1143-1144, 2023.

Article de En | MEDLINE | ID: mdl-37927273

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myopathie de Duchenne Limites: Humans / Male Langue: En Journal: J Neuromuscul Dis Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google